USPTO serial 98583104
ONE HOME FOR SITES
Reviewed by CopyMark Law Group
Status 760
- Filing date
- Status date
- Registration date
- —
- Examiner
- LORENZO, KATHLEEN H
- Law office
- TMEG LAW OFFICE 109
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ONE HOME FOR SITES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Parsippany, NJ, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CYNTHIA JOHNSON WALDEN
Cynthia Johnson Walden Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting, administrative, management, and information services in the field of clinical trials; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, biologics, and devices with governmental regulatory bodies; Providing business consulting services in the field of clinical research, and clinical trials; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug, biologics, and device approval; Recruitment services, namely, advertising clinical trials, recruiting patients, and placing patients for participation in clinical trials for testing of drugs, biologics, and devices; Providing a website and online portal featuring business information in the pharmaceutical and life sciences fields; Providing independent review of clinical trials for business purposes; Database management and data processing services; Business networking and online business networking services; Management and compilation of business directories and registries; Online business directories featuring information on clinical trials, clinical trial professionals, and patients in clinical trials; all aforementioned services relating to clinical trials; none of the aforementioned services relating to at home care | ACTIVE | — |
| 042 | Scientific research in the field of clinical trials, pharmaceuticals, biologics, and devices; Scientific research, namely, conducting clinical trials and providing documentation for submission to regulatory authorities in connection therewith; Providing scientific research information in the field of clinical trials, pharmaceuticals, biologics, and devices; Pharmaceutical drug, biologic, and device development services; Providing scientific research information in the field of clinical trials, pharmaceuticals, biologics, and devices via online searchable database; Research and development of new products for others; Consulting services in the field of contract clinical research and contract product development; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Providing scientific research information to pharmaceutical and biotechnology companies; Providing an online non-downloadable database in the field of clinical trials for scientific research purposes; Online non-downloadable software, software as a service (SaaS) featuring software for, platform as a service (PAAS) featuring software for, and online non-downloadable cloud-based software providing clinical trial, pharmaceutical, medical, healthcare, and life sciences information and analysis; Online non-downloadable software, software as a service (SaaS) featuring software for, platform as a service (PAAS) featuring software for, and online non-downloadable cloud-based software accessing, collecting, managing, tracking, analyzing, and reporting data in the clinical trial, pharmaceutical and life sciences fields; Online non-downloadable software, software as a service (SaaS) featuring software for, platform as a service (PAAS) featuring software for, and online non-downloadable cloud-based software for scientific research and clinical trials; Online non-downloadable software, software as a service (SaaS) featuring software for, platform as a service (PAAS) featuring software for, and online non-downloadable cloud-based software for collecting, managing, and analyzing clinical trial data; Scientific and new product development research, consulting, and support services; Contract clinical research and contract product developments; all aforementioned services relating to clinical trials; none of the aforementioned services relating to at home care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 9, 2026 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 9, 2026 | GNSF | SUBSEQUENT FINAL EMAILED | — |
| Aug 9, 2026 | CFRC | SUBSEQUENT FINAL REFUSAL WRITTEN | — |
| May 7, 2026 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Feb 21, 2026 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 21, 2026 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 21, 2026 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Dec 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 11, 2025 | ALIE | ASSIGNED TO LIE | — |
| Nov 28, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 28, 2025 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Nov 28, 2025 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Nov 28, 2025 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Aug 26, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 26, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 28, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 28, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 28, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 31, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 30, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2024 | NWAP | NEW APPLICATION ENTERED | — |